Publications

LATEST PUBLICATIONS

• Davis DR, Kizana E, Terrovitis I, Barth AS, Smith R, Miake J, Marbán E. Rapid uncomplicated method for isolating and expanding functionally-competent cardiac progenitor cells from multiple regions of the heart. Circulation Research 2009;103(12):1493-1501.
• White AJ, Matsushita S, Chakravarty T, Czer LS, Burton K, Scwartz ER, Davis DR, Simsir S, Reinsmoen NL, Forrester JS, Marbán E, Makkar R. Human Cardiac stem cells originate within the heart. JACC 2009.
• Davis DR, Marban E. Direct cellular outgrowth from cardiac tissue expresses stem cell markers and improves function after myocardial infarction. To be presented at CCC 2009.
• Mahmoud S, Davis DR, Beauchesne L, Glover C. Acute reversible left ventricular dysfunction secondary to alcohol. Can J Cardiol 2007;23(6):475-477.
• Davis DR, Tang ASL, Samie R, Al-Rawahi N, Green MS, Lemery R, Gollob M, Birnie DH. Remote magnetic navigation enhances catheter stability and substrate contact. PACE 2008.

PAPERS IN REFEREED JOURNALS

• Davis, D.R., The effect of dofetilide on ventricular action potential duration and refractoriness with monophasic and biphasic shocks in dogs., B.Sc. Thesis, McMaster University, 40 pp., 1995.
• Beatch, G.N., Davis, D.R., Laganière, S. and Williams, B.A., Rate-dependent effects of sematilide on ventricular monophasic action potential duration and delayed rectifier K+ current in rabbits., J. Card. Pharm. 28:618-630., 1996.
• Davis, D.R., Tang, A.S.L. and Beatch G.N., Synergistic effects of class III antiarrhythmics and implantable cardioverter-defibrillators.,Current Drugs; ID research alerts 1(6):1-7, 1996.
• Dickenson, D.R., Davis, D.R. and Beatch, G.N., Development and evaluation of a fully automated monophasic action potential analysis program., Med. Biol. Eng. Comp. 35(6):653-660, 1997.
• Davis, D.R., Mechanism of defibrillation: The relationship between myocardial mass and defibrillation energy requirements., B.M.S. Thesis, Ottawa University, 50 pp. 1997.
• Beatch, G.N., Davis, D.R. and Dickenson, D.R., Proarrhythmic effects of intravenous almokalant in baboons., Proc. West. Pharmacol. Soc., 1997.
• Davis, D.R., Beatch, G.N., Dickenson, D.R., and Tang, A.S.L., Dofetilide increases shock refractory period extension and lowers defibrillation threshold., Canadian Journal of Cardiology. 15(2):193-200, 1999.
• Van Walraven, C., Davis, D.R., Forster, A., and G. Wells, Time-dependent bias was common in survival analyses published in leading clinical journals, J Clin Epi. 57:672-682, 2004.
• Davis, D.R. and Tang, A.S.L., Implantable Cardioverter Defibrillators: Therapy against Canada’s leading killer. CMAJ 171(9): 1037-1038, 2004.
• Davis, D.R., Krahn, A.D., Tang, A.S.L., Lemery, R., Green, M.S., Yee, R., Skanes, A.C., Klein, G.J. and Birnie D.H., Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure, Can J Cardiol. 21(5):413-7, 2005.
• Mielniczuk, L., Williams, K., Davis, D.R., Tang, A.S.L., Lemery, R., Gollob, M.H., Haddad, H., Birnie, D.H. Frequency of Peripartum Cardiomyopathy, Am. J. Cardiol. 97(12):1765-1768, 2006.
• Birnie, D.H., Williams, K., Mielniczuk, L., Davis, D.R., Lemery, R., Green, M.S., Gollob, M.H., Guo, A., and Tang, A.S.L., Reasons for Escalating Pacemaker Implants, Am. J. Cardiol. 98(1):93-97, 2006.
• Davis, D.R., Birnie, D.H., Green, M.S., Lemery, R., Gollob, M. and Tang, A.S.L., Effect of gender on bias for referral for ICD. Europace 8(12):1054-1056, 2006.
• Davis, D.R., Birnie, D.H., Tang, A.S.L., Green, M.S., and Gollob, M.H. Successful ablation of a concealed parahisian accessory pathway using a remote control navigation system following failure by conventional methods. JICE 16(3):149-151, 2006.
• Davis, D.R., Gollob M.H., Green, M.S., Lemery, R., Tang, A.S.L., Birnie, D.H., Appropriate result from an inappropriate ICD shock, PACE (29):1183–1184, 2006.
• Davis, D.R., Gollob M.H., Green, M.S., Lemery, R., Tang, A.S.L., Birnie, D.H., Transient left ventricular apical ballooning associated with a prolonged electrophysiology procedure, JICE 17(1): 47-49, 2007.
• Davis, D.R., Kizana, E., Terrovitis, I., Barth, A.S., Smith, R., Miake, J. and Marbán, E., Rapid uncomplicated method for isolating and expanding functionally-competent cardiac progenitor cells from multiple regions of the heart. Circulation Research 103[12], 1493-1501, 2009.
• White, A.J., Matsushita, S., Chakravarty, T., Czer, L.S., Burton, K., Scwartz, E.R., Davis, D.R., Simsir, S., Reinsmoen, N.L., Forrester, J.S., Marbán, E., Makkar, R., Human Cardiac stem cells originate within the heart, JACC 2009
• Davis, D.R., Marban, E. Direct Cellular Outgrowth From Cardiac Tissue Expresses Stem Cell Markers And Improves Function After Myocardial Infarction. To be presented at CCC 2009.
• Mahmoud, S., Davis, D.R., Beauchesne, L. and Glover, C., Acute reversible left ventricular dysfunction secondary to alcohol., Can. J. Cardiol. 23(6): 475-477, 2007.
• Davis, D.R., Tang, A.S.L., Samie, R., Al-Rawahi, N., Green, M.S., Lemery, R., Gollob, M. and Birnie, D.H., Remote magnetic navigation enhances catheter stability and substrate contact, PACE 2008.

ABSTRACTS

• Davis, D.R., Beatch, G.N. and Laganière, S., The frequency dependent effects of sematilide in rabbits., Can. J. Physiol. Pharmacol. 72(S1): 81, 1994.
• Laganière, S., Beatch, G.N., Goenert, L. and Davis, D.R., Pharmacokinetics and pharmacodynamics of intravenous sematilide in anaesthetized rabbits., Can. J. Physiol. Pharmacol. 72(S1): 80, 1994.
• Beatch, G.N., Dickenson, D.R., Davis, D.R. and Tang, A.S.L., Dofetilide: Relationship between refractory period extension and defibrillation threshold., PACE 18:820, 1995.
• Skanes, A., Davis, D.R., Dickenson, D.R., Beatch, G.N. and Tang, A.S.L., The effect of monophasic and biphasic shocks on the refractory period extension in dogs.,Can.J.Cardiol.11(Suppl.E):97E, 1995.
• Davis, D.R. and Tang, A.S.L., Critical mass of low gradient field required for defibrillation., Can. J. Cardiol. 11(Suppl. E):163, 1999.
• Davis, D.R., Birnie, D.H., Dalipaj, M.H., Ruddy, T.H. and Tang, A.S.L., Septal Mechanics are Improved by Atrio-Biventricular Pacing in Patients with Severe Heart Failure and Conduction Delay. Can. J. Cardiol. 15(Suppl. D):223, 2001.
• Davis, D.R., Krahn, A.D., Tang, A.S.L., Lemery, R., Green, M.S., Yee, R., Skanes, A.C., Klein, G.J. and Birnie D.H., Long-term follow-up of cardiac resynchronization from two Canadian centers, Presented at Heart Rhythm 2004.
• Davis, D.R., Lau, E., Birnie, D.H., Green, M.G., Lemery, R., and Tang, A.S.L., When does a limited ICD make economic sense? Can. J. Cardiol. 20(Suppl. D):142, 2004.
• Davis, D.R., Lau, E., Birnie, D.H., Green, M.G., Lemery, R., Gollob, M. and Tang, A.S.L., Gender disparity in implanted cardioverter defibrillator therapy. Can. J. Cardiol. 20(Suppl. D):147, 2004.
• Davis, D.R., Lau, E., Birnie, D.H., Green, M.G., Lemery, R., Gollob, M. and Tang, A.S.L., Inappropriate Shocks in ICD Patients: A Comparison Between ICDs Implanted for Primary and Secondary Prevention. Can. J. Cardiol. 20(Suppl. D):404, 2004.
• Davis, D.R., Lau, E., Birnie, D.H., Green, M.G., Lemery, R., and Tang, A.S.L., Inappropriate Shocks in ICD Patients: A Cost Efficacy Analysis of ICD Insertion for Primary Prevention. Presented at CCC 2004.
• Mielniczuk L., Davis D.R., Haddad H., Williams K., Birnie D.H., Estimating the True Prevalence, Mortality and Morbidity of Peripartum Cardiomyopathy. Presented at Heart Failure Society Meeting 2004.
• Mielniczuk L., Davis D.R., Haddad H., Williams K., Birnie D.H., Estimating the True Prevalence, Mortality and Morbidity of Peripartum Cardiomyopathy. Can. J. Cardiol. 20(Suppl. D):385, 2004.
• Mielniczuk L., Davis D.R., Haddad H., Williams K., Birnie D.H., Estimating the True Prevalence, Mortality and Morbidity of Peripartum Cardiomyopathy. Presented at AHA 2004.
• Mielniczuk, L., Davis, D.R., Haddad, H., Wiliams, K., Birinie, D.H., Estimating the True Prevalence, Mortality and Morbidity of Peripartum Cardiomyopathy. Accepted at Heart Failure Society Meeting 2004: Presented at AHA 2004.
• Davis, D.R., Jiang, H., Green, M.S., Gow, R., Birnie, D.H., Tang, A.S.L., Lemery, R., Honeywell, C., Chen, S.W., Gollob, M.H., Clinical characterization and molecular identification of a novel mutation in a highly conserved region of the RyR2 gene associated with catecholaminergic polymorphic ventricular tachycardia, The Canadian Journal of Cardiology 17 (Suppl. C): 206C, October 2005
• Davis, D.R., Jiang, H., Green, M.S., Gow, R., Birnie, D.H., Tang, A.S.L., Lemery, R., Honeywell, C., Chen, S.W., Gollob, M.H., Clinical characterization and molecular identification of a novel mutation in a highly conserved region of the RyR2 gene associated with catecholaminergic polymorphic ventricular tachycardia, AHA 2005
• Davis, D.R., Huang, H., Green, M.S., Gow, R., Birnie, D.H., Tang, A.S.L., Honeywell, C., Lemery, R., Chahine, M. and Gollob, M.H., A rare mixed phenotype of Brugada Syndrome and Conduction System Disease caused by a novel SCN5A mutation, The Canadian Journal of Cardiology 17 (Suppl. C): 206C, October 2005.
• Birnie, D.H., Williams, K., Mielniczuk, L., Davis, D.R., Lemery, R., Green, M.S., Gollob, M.H. and Tang, A.S., Influence of the Mode Selection Trial in Sinus-Node Dysfunction (MOST) on Pacing Practice in the United States, Presented at AHA 05.
• Birnie, D.H., Williams, K., Mielniczuk, L., Davis, D.R., Lemery, R., Green, M.S., Gollob, M.H. and Tang, A.S., Escalating Pacemaker Implants in the US is due to Increasing Implantation for Sinus Node Dysfunction, Presented at AHA 05.
• Davis, D.R., Birnie, D.H., Tang, A.S.L., Samie, R., Al-Rawahi, N., Green, M.S., and Gollob, M.H. Successful ablation of a concealed parahisian accessory pathway using remote control magnetic navigation following failure of conventional methods. Heart Rhythm 3(1S): P4-112.
• Davis, D.R., Gow, R., Birnie, D.H., Green, M.S., Honeywell, C., Tang, A.S.L., Roberts, R. and Gollob, M.H. Syncope While Swimming: Identification of Novel RyR2 Mutations. Heart Rhythm 3(1S): P4-62.
• Davis, D.R., Huang, H., Green, M.S., Gow, R., Birnie, D.H., Tang, A.S.L., Rutberg, J., Honeywell, C., Lemery, R., Chahine, M. and Gollob, M.H., Clinical and Molecular Characterization of a Novel SCN5A Mutation Resulting in a Rare Mixed Phenotype of Brugada Syndrome and Conduction Disease. Heart Rhythm 3(1S): AB47-6.
• Samie, R., Davis, D.R., Birnie, D.H., Green, M.S., Al-Rawahi, N., Tang, A.S.L., and Gollob, M.H. Procainamide-induced Ventricular Fibrillation during Treatment of Atrial Fibrillation Unmasks a Mutation of SCN5A. Heart Rhythm 3(1S): AB11-3.
• Amhalhal, I., Davis, D.R., Pipe, A.L., Jamnik, V.K.,Gledhill, N. and Green, M.S. What is a “normal” electrocardiogram in an elite hockey player? (Canadian Academy of Sports Medicine, May 2006, Edmonton).
• Davis, D.R., Gow, R., Birnie, D.H., Green, M.S., Honeywell, C., Tang, A.S.L., Roberts, R. and Gollob, M.H. Syncope While Swimming: Identification of Novel RyR2 Mutations. Presented at CCC 06.
• Al-Rawahi, N., Davis, D.R., Birnie, D.H., Gollob, M.H., Samie, R., Lemery, R., Green, M.S. and Tang, A.S.L. The Use of a Novel Magnetic Navigation System for Remote Catheter Ablation of Ischemic Ventricular Tachycardia. Presented at CCC 06.
• Kenk, M., Lortie, M., Thorne, S., Davis, D.R., Birnie, D.H., Labinaz, M., Tang, A.S.L., DeKemp, R., Beanlands, R.S., and DaSilva J.N. Imaging myocardial CAMP-specific phosphodiesterase-4 activity in canine models. Presented at CCC 06.
• Samie, R., Birnie, D.H., Al-Rawahi, N., Farwell, D., Gollob, M.H., Green, M.S., Davis, D.R., Lemery, R., Tang, A.S.L. The Ability of Remote Magnetic Navigation Catheter Ablation to Isolate Pulmonary Veins. Presented at Heart Rhythm 07.